Mepolizumab effectiveness in patients with severe eosinophilic asthma and co-presence of bronchiectasis: A real-world retrospective pilot study
Claudia Crimi(Marconi University), Nunzio Crimi(University of Catania), Raffaele Campisi(University of Catania), Corrado Pelaia(Magna Graecia University), Santi Nolasco(University of Catania), Rossella Intravaia(University of Catania), Pietro Impellizzeri(Azienda Ospedaliero-Universitaria Policlinico - Vittorio Emanuele), Morena Porto(University of Catania), Giulia Cacopardo(University of Catania)
Cited by 57
Related Papers
A European survey of noninvasive ventilation practices
|European Respiratory Journal|2010|205
Determinants of tracheostomy decannulation: an international survey
|Critical Care|2008|177
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study
|Arthritis & Rheumatology|2021|165
Interleukins 4 and 13 in Asthma: Key Pathophysiologic Cytokines and Druggable Molecular Targets
|Frontiers in Pharmacology|2022|157
Molecular Targets for Biological Therapies of Severe Asthma
|Frontiers in Immunology|2020|132